Each tier must be licensed by a state and/or local regulatory body to operate within a specific state, and each state maintains its own regulatory scheme
10.2337/dc12-2709 61 RosenstockJ.HanefeldM.ShamannaP.MinK
Nausea, diarrhea, vomiting, constipation, and dyspepsia are documented in clinical trials, with higher doses generally associated with increased frequency and severity of these symptoms
Journal of Clinical Endocrinology and Metabolism, 97 ,
In clinical publications, CS10 (CagriSema) is described as a combination acting simultaneously on two independent satiety mechanisms
We cap our calculator at 15% below maintenance